Clinical Trial Update: Thiopurine Methyltransferase Polymorphisms Evaluation

View source ↗

Summary

A clinical trial evaluating thiopurine methyltransferase polymorphisms in cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Cancer | Status: WITHDRAWN